In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
Lina Irawan
Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...
Introduction In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged in popularity as powerful tools for...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have surged into...
In a move that underscores the shifting landscape of global pharmaceutical R&D, Roche has announced a massive...
Introduction: The Architecture of Community In the landscape of public service and non-profit advocacy, certain figures emerge...
The landscape of oncology is undergoing a seismic shift, particularly in the realm of metastatic breast cancer...
For decades, the diagnosis of metastatic cancer was synonymous with a shift from curative to palliative care....
TORONTO, ON — As the medical community and advocacy groups gear up for Breast Cancer Awareness Month...
